Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
397.48
+3.28 (0.83%)
Nov 20, 2024, 4:00 PM EST - Market closed
Elevance Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Elevance Health stock have an average target of 543.07, with a low estimate of 478 and a high estimate of 649. The average target predicts an increase of 36.63% from the current stock price of 397.48.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ELV stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 | 5 | 4 |
| Buy | 9 | 9 | 8 | 8 | 8 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 15 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $585 → $505 | Buy | Maintains | $585 → $505 | +27.05% | Nov 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $593 → $495 | Buy | Maintains | $593 → $495 | +24.53% | Nov 4, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $643 → $551 | Buy | Maintains | $643 → $551 | +38.62% | Oct 23, 2024 |
| Barclays | Barclays | Buy Maintains $622 → $501 | Buy | Maintains | $622 → $501 | +26.04% | Oct 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $589 → $484 | Strong Buy | Maintains | $589 → $484 | +21.77% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
176.80B
Revenue Next Year
190.39B
from 176.80B
Increased by 7.68%
EPS This Year
33.29
from 25.22
Increased by 32.01%
EPS Next Year
35.30
from 33.29
Increased by 6.04%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 185.7B | 202.8B | 220.5B | |
| Avg | 176.8B | 190.4B | 205.1B | |
| Low | 169.5B | 178.9B | 191.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 14.7% | 15.8% | |
| Avg | - | 7.7% | 7.7% | |
| Low | - | 1.2% | 0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.77 | 43.68 | 48.67 | ||
| Avg | 33.29 | 35.30 | 41.23 | ||
| Low | 31.54 | 30.82 | 37.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 37.8% | 31.2% | 37.9% | ||
| Avg | 32.0% | 6.0% | 16.8% | ||
| Low | 25.0% | -7.4% | 4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.